bioAffinity Technologies, Inc. Rings the Closing Bell

About This Event

bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage lung cancer, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Maria Zannes, President, Chief Executive Officer and Board Member of bioAffinity, rings the Closing Bell.

Read more…

Request a Call Back

Contact Info